Scilife Webinar: Helius, the first medicinal cannabis company in New Zealand to be GMP certified

Find out how Helius Therapeutics became the first GMP-certified medicinal cannabis company in New Zealand. The country where the legislation to enable a medicinal cannabis industry was just recently passed. There are always challenges to the first-mover advantage. That's what Carmen Doran, CEO at Helius Therapeutics, will talk about in this free Scilife webinar session! Helius is setting the standard for effective and accessible medicinal cannabis products in New Zealand and beyond. The company operates a state-of-the-art, integrated facility in Auckland with indoor controlled growing systems, an extraction site, an advanced cannabinoid research laboratory, and manufacturing. Agenda: ➡️ Advantages and disadvantages of being the first. ➡️ How to tackle the #regulatory requirements of new market opportunities. ➡️ Challenges of merging cannabis agriculture with the pharma industry.